Empowering Patients, Enhancing Safety
Patient safety is paramount in today's healthcare landscape, and pharmacovigilance (PV) is imperative to ensure drug safety. HCLTech is at the forefront of integrating advanced digital technologies with human expertise to enhance PV processes. We offer industry-leading services and software portfolios to empower effective PV.
As part of our commitment to advancing drug safety, we are excited to participate in the upcoming World Drug Safety Congress Americas (WDSC) 2023, the largest commercial gathering of PV and biopharma professionals worldwide.
Our GPV&E (Global Pharmacovigilance and Epidemiology) team will demonstrate how we capture, analyze and aggregate a comprehensive 360-degree view of the safety profile of products.
So, join us at booth #608 to explore how HCLTech is transforming PV through digital innovation, revolutionizing drug safety protocols and contributing to a future where patient well-being is at the forefront of healthcare.
Advancing PV with Next-gen Solutions
Harnessing the power of Generative AI, our pharmacovigilance solutions streamline case intake, automate intelligent aggregate and risk mitigation action plan (RMP) authoring, enable efficient adverse event identification and ensure robust quality control. By leveraging advanced AI algorithms, our solutions enhance the entire pharmacovigilance process, making it more efficient and effective.
Our Analyst Recognitions
HCLTech positioned as a Leader in ISG Provider Lens™ Clinical Development Digital Transformation Services, 2021
HCLTech positioned as a Leader in ISG Provider Lens™ Patient Engagement Digital Transformation Services, 2021
HCLTech positioned as a Leader in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment, 2022
Our Resources
Subscribe to the HCLTech Newsletter
for our latest news and insights